Impact Factor
3.36
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.38
855 total citations
h5-index
36
h5 depth signal
Cited share
62.2%
235 of 378
Total citations
855
Citation footprint
Metric signal
2.88
External metric anchor
Self-citation
4.6%
39 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,282
China
321
Japan
238
Italy
125
Canada
98
Citing Fields of Research
Oncology
551
Musculoskeletal & Nerve Cancer
315
Liver & Colon Cancer
253
Urology
221
Breast Cancer
211
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
14,808
Articles tracked across the journal lifetime
Indexed publication set
378
235 cited publications
Last 12 months
252
21.0 publications/month
Open access share
18.3%
46 OA publications in the last year
Leading citing country
United States
1,282 citing publications
Leading citing field
Oncology
551 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v2n1,Mar. 1971-
v2n1,Mar. 1971-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Urology
Breast Cancer
Lymphomas
Musculoskeletal & Nerve Cancer
Reproductive Health
Broad Categories
Pathology
Musculoskeletal & Nerve Cancer
Lymphomas
Urology
Liver & Colon Cancer
Digestive Disorders
Auto-Inflammatory Disorders
MeSH Descriptors
Pathology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.humpath.2026.106285
Open DOI
Routine prostate biopsy reports carry grade-specific tumor burden information beyond the highest Grade Group
02
DOI 10.1016/j.humpath.2026.106281
Open DOI
Aberrant HER2 Expression as a Specific and Feasible Diagnostic Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
03
04
DOI 10.1016/j.humpath.2026.106273
Open DOI
Comprehensive Genomic Characterization of Primary Dermal Melanoma: Delineating it from Metastatic Melanoma with Unknown Primary
05
06
DOI 10.1016/j.humpath.2026.106276
Open DOI
Expanding the clinicopathological spectrum of BAP1 mutated ccRCC: a study of 84 cases in multi-center cohort
07
08
09
10
DOI 10.1016/j.humpath.2026.106280
Open DOI
Papillary endothelial hyperplasia in late post-radiation or late post-operative breast hematomas mimicking angiosarcoma
Bibliographical & Catalog Notes
Also issued online.
19950524 Not printed on acid-free paper